95C: THE ASSOCIATION BETWEEN CLOSED SUCTION DRAINAGE DURATION AND COMPLICATION RATES IN TISSUE EXPANDER/IMPLANT BREAST RECONSTRUCTION WITH ANTIBIOTIC PROPHYLAXIS

2010 ◽  
Vol 125 (Supplement) ◽  
pp. 67 ◽  
Author(s):  
ST Lanier ◽  
ED Wang ◽  
BT Phillips ◽  
SU Khan ◽  
AB Dagum ◽  
...  
Keyword(s):  
Breast Reconstruction ◽  
Antibiotic Prophylaxis ◽  
Tissue Expander ◽  
Complication Rates ◽  
Suction Drainage ◽  
Closed Suction ◽  
Closed Suction Drainage ◽  
Implant Breast Reconstruction

scholarly journals Effects of disusing closed suction drainage in simultaneous bilateral total hip arthroplasty: A retrospective cohort study

PLoS ONE ◽  
2021 ◽  
Vol 16 (3) ◽  
pp. e0247845
Author(s):  
Chan-Woo Park ◽  
Seung-Jae Lim ◽  
Insun Yoo ◽  
Youngsik Lee ◽  
Jae-Yeon Won ◽  
...  
Keyword(s):  
Blood Loss ◽  
Transfusion Requirement ◽  
Postoperative Blood Loss ◽  
Transfusion Rate ◽  
Complication Rates ◽  
Suction Drainage ◽  
Closed Suction ◽  
Closed Suction Drainage ◽  
Hemoglobin Drop

Purpose Increased blood loss remains a major drawback of simultaneous bilateral total hip arthroplasty (SBTHA). We examined the effects of disusing closed suction drainage (CSD) on postoperative blood loss and transfusion requirement in cementless SBTHA. Methods A retrospective cohort study was conducted with a consecutive series of cementless SBTHAs performed by a single surgeon between January 2014 and March 2017. The surgeon routinely used CSD until May 2015 and refrained from CSD in all primary THAs thereafter. This study included SBTHAs with intravenous administration of tranexamic acid (TXA). Postoperative hemoglobin drop, blood loss, transfusion rate, pain scores, complication rates, and implant survivorships were compared between the groups of SBTHA with and without CSD. The minimum follow-up duration was 1 year. Results Among the 110 patients (220 hips), 46 (92 hips) and 64 (128 hips) underwent SBTHA with and without CSD, respectively. Maximum hemoglobin drop (mean, 4.8 vs. 3.9 g/dL; P = 0.001), calculated blood loss (mean, 1530 vs. 1190 mL; P<0.001), transfusion rate (45.7% vs. 21.9%; P = 0.008), and length of hospital stay (mean, 6.6 vs. 5.8 days; P = 0.004) were significantly lower in patients without CSD. There were no significant differences in postoperative pain scales and wound complication rates. The mean Harris Hip scores at final follow-up (92.5 vs. 92.1; P = 0.775) and implant survivorships with an end-point of any revision at 4 years (98.9% vs. 98.4%; log-rank, P = 0.766) were similar between groups. Conclusions Disusing CSD significantly reduced postoperative blood loss and transfusion requirement without increasing postoperative pain and surgical wound complications in cementless SBTHA with concurrent administration of intravenous TXA.

The Effect of Acellular Dermal Matrix Use on Complication Rates in Tissue Expander/Implant Breast Reconstruction

2010 ◽  
Vol 64 (5) ◽  
pp. 674-678 ◽  
Author(s):  
Steven T. Lanier ◽  
Eric D. Wang ◽  
John J. Chen ◽  
Balvant P. Arora ◽  
Steven M. Katz ◽  
...  
Keyword(s):  
Breast Reconstruction ◽  
Tissue Expander ◽  
Acellular Dermal Matrix ◽  
Complication Rates ◽  
Dermal Matrix ◽  
Acellular Dermal ◽  
Implant Breast Reconstruction

scholarly journals Long-term outcomes of two-stage, immediate and delayed breast reconstruction with polyurethane-covered versus textured implants: protocol of a prospective, multicentre randomised controlled trial (TIPI trial)

BMJ Open ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. e044219
Author(s):  
J X Harmeling ◽  
Kevin Peter Cinca ◽  
Eleni-Rosalina Andrinopoulou ◽  
Eveline M L Corten ◽  
M A Mureau
Keyword(s):  
Randomised Controlled Trial ◽  
Breast Reconstruction ◽  
Controlled Trial ◽  
Capsular Contracture ◽  
Tissue Expander ◽  
Complication Rates ◽  
Two Stage ◽  
Randomised Controlled

IntroductionTwo-stage implant-based breast reconstruction is the most commonly performed postmastectomy reconstructive technique. During the first stage, a tissue expander creates a sufficiently large pocket for the definite breast implant placed in the second stage. Capsular contracture is a common long-term complication associated with implant-based breast reconstruction, causing functional complaints and often requiring reoperation. The exact aetiology is still unknown, but a relationship between the outer surface of the implant and the probability of developing capsular contracture has been suggested. The purpose of this study is to determine whether polyurethane-covered implants result in a different capsular contracture rate than textured implants.Methods and analysisThe Textured Implants versus Polyurethane-covered Implants (TIPI) trial is a multicentre randomised controlled trial with a 1:1 allocation rate and a follow-up of 10 years. A total of 321 breasts of female adults undergoing a two-stage breast reconstruction will be enrolled. The primary outcome is capsular contracture at 10-year follow-up which is graded with the modified Baker classification. It is analysed with survival analysis using a frailty model for clustered interval-censored data, with both an intention-to-treat and per-protocol approach. Secondary outcomes are other complication rates, surgical revision rate, patient satisfaction and quality of life and user-friendliness. Outcomes are measured 2 weeks, 6 months, 1, 2, 3, 5 and 10 years postoperatively. Interim analysis is performed when 1-year, 3-year and 5-year follow-up is completed.Ethics and disseminationThe trial has been reviewed and approved by the Medical Research Ethics Committee of the Erasmus MC, University Medical Centre Rotterdam (MEC-2018-126) and locally by each participating centre. Written informed consent will be obtained from each study participant. The results will be disseminated by publication in peer-reviewed journals.Trial registrationNTR7265.

Sign in / Sign up

Export Citation Format

Share Document